FdaApplication
NDA 020444
Identifiers
- fda_app_no: NDA020444
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1995-09-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLOLAN | EPOPROSTENOL SODIUM | EQ 0.5MG BASE/VIAL | INJECTABLE;INJECTION |
| FLOLAN | EPOPROSTENOL SODIUM | EQ 1.5MG BASE/VIAL | INJECTABLE;INJECTION |
2 products